Phibro Animal Health Corporation reported earnings results for the third quarter and nine months ended March 31, 2024. For the third quarter, the company reported sales was USD 263.2 million compared to USD 245.7 million a year ago. Net income was USD 8.4 million compared to USD 10 million a year ago. Basic earnings per share from continuing operations was USD 0.21 compared to USD 0.25 a year ago. Diluted earnings per share from continuing operations was USD 0.21 compared to USD 0.25 a year ago.
For the nine months, sales was USD 744.5 million compared to USD 722.8 million a year ago. Net income was USD 1.7 million compared to USD 21.1 million a year ago. Basic earnings per share from continuing operations was USD 0.04 compared to USD 0.52 a year ago. Diluted earnings per share from continuing operations was USD 0.04 compared to USD 0.52 a year ago.